United States Cancer Immunotherapy Market Research Report Forecast 2017-2021
The United States Cancer Immunotherapy Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cancer Immunotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Immunotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
United States Cancer Immunotherapy Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Cancer Immunotherapy Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
United States Cancer Immunotherapy Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Cancer Immunotherapy Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 CANCER IMMUNOTHERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Cancer Immunotherapy Market Segmentation by Type
1.2.1 United States Production Market Share of Cancer Immunotherapy by Type in 2015
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Cancer Immunotherapy Market Segmentation by Application
1.3.1 Cancer Immunotherapy Consumption Market Share by Application in 2015
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Immunotherapy (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON CANCER IMMUNOTHERAPY INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES CANCER IMMUNOTHERAPY MARKET COMPETITION BY MANUFACTURERS
3.1 United States Cancer Immunotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 United States Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Cancer Immunotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Immunotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Immunotherapy Market Competitive Situation and Trends
3.5.1 Cancer Immunotherapy Market Concentration Rate
3.5.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES CANCER IMMUNOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Cancer Immunotherapy Production and Market Share by Type (2012-2017)
4.2 United States Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Immunotherapy Price by Type (2012-2017)
4.4 United States Cancer Immunotherapy Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES CANCER IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION
5.1 United States Cancer Immunotherapy Consumption and Market Share by Application (2012-2017)
5.2 United States Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 AstraZeneca
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 F. Hoffman La-Roche
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Bayer AG
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Bristol-Myers Squibb
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Eli Lilly and Company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Janssen Global Services
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Merck
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Novartis
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS
7.1 Cancer Immunotherapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Immunotherapy
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Cancer Immunotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES CANCER IMMUNOTHERAPY MARKET FORECAST (2017-2021)
11.1 United States Cancer Immunotherapy Production, Revenue Forecast (2017-2021)
11.2 United States Cancer Immunotherapy Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Cancer Immunotherapy Production Forecast by Type (2017-2021)
11.4 United States Cancer Immunotherapy Consumption Forecast by Application (2017-2021)
11.5 Cancer Immunotherapy Price Forecast (2017-2021)
CHAPTER 12 APPENDIX
1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Cancer Immunotherapy Market Segmentation by Type
1.2.1 United States Production Market Share of Cancer Immunotherapy by Type in 2015
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Cancer Immunotherapy Market Segmentation by Application
1.3.1 Cancer Immunotherapy Consumption Market Share by Application in 2015
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Immunotherapy (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON CANCER IMMUNOTHERAPY INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES CANCER IMMUNOTHERAPY MARKET COMPETITION BY MANUFACTURERS
3.1 United States Cancer Immunotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 United States Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Cancer Immunotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Immunotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Immunotherapy Market Competitive Situation and Trends
3.5.1 Cancer Immunotherapy Market Concentration Rate
3.5.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES CANCER IMMUNOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Cancer Immunotherapy Production and Market Share by Type (2012-2017)
4.2 United States Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Immunotherapy Price by Type (2012-2017)
4.4 United States Cancer Immunotherapy Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES CANCER IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION
5.1 United States Cancer Immunotherapy Consumption and Market Share by Application (2012-2017)
5.2 United States Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 AstraZeneca
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 F. Hoffman La-Roche
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Bayer AG
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Bristol-Myers Squibb
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Eli Lilly and Company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Janssen Global Services
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Merck
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Novartis
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS
7.1 Cancer Immunotherapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Immunotherapy
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Cancer Immunotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES CANCER IMMUNOTHERAPY MARKET FORECAST (2017-2021)
11.1 United States Cancer Immunotherapy Production, Revenue Forecast (2017-2021)
11.2 United States Cancer Immunotherapy Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Cancer Immunotherapy Production Forecast by Type (2017-2021)
11.4 United States Cancer Immunotherapy Consumption Forecast by Application (2017-2021)
11.5 Cancer Immunotherapy Price Forecast (2017-2021)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Cancer Immunotherapy
Table Classification of Cancer Immunotherapy
Figure United States Sales Market Share of Cancer Immunotherapy by Type in 2015
Table Application of Cancer Immunotherapy
Figure United States Sales Market Share of Cancer Immunotherapy by Application in 2015
Figure United States Cancer Immunotherapy Sales and Growth Rate (2011-2021)
Figure United States Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Table United States Cancer Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Sales Share by Manufacturers
Figure 2016 Cancer Immunotherapy Sales Share by Manufacturers
Table United States Cancer Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 United States Cancer Immunotherapy Revenue Share by Manufacturers
Table United States Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015
Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers
Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers
Table United States Cancer Immunotherapy Sales by Type (2012-2017)
Table United States Cancer Immunotherapy Sales Share by Type (2012-2017)
Figure United States Cancer Immunotherapy Sales Market Share by Type in 2015
Table United States Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
Table United States Cancer Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Immunotherapy by Type (2012-2017)
Table United States Cancer Immunotherapy Price by Type (2012-2017)
Figure United States Cancer Immunotherapy Sales Growth Rate by Type (2012-2017)
Table United States Cancer Immunotherapy Sales by Application (2012-2017)
Table United States Cancer Immunotherapy Sales Market Share by Application (2012-2017)
Figure United States Cancer Immunotherapy Sales Market Share by Application in 2015
Table United States Cancer Immunotherapy Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Immunotherapy Sales Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Immunotherapy Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Immunotherapy Market Share (2012-2017)
Table F. Hoffman La-Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffman La-Roche Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffman La-Roche Cancer Immunotherapy Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Cancer Immunotherapy Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Immunotherapy Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly and Company Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Cancer Immunotherapy Market Share (2012-2017)
Table Janssen Global Services Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Global Services Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Global Services Cancer Immunotherapy Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Immunotherapy Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Immunotherapy Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure United States Cancer Immunotherapy Production and Growth Rate Forecast (2017-2021)
Figure United States Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Table United States Cancer Immunotherapy Production Forecast by Type (2017-2021)
Table United States Cancer Immunotherapy Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
Pfizer
Seattle Genetics
Peregrine Pharmaceuticals
Viralytics Ltd
Immunomedics
Figure Picture of Cancer Immunotherapy
Table Classification of Cancer Immunotherapy
Figure United States Sales Market Share of Cancer Immunotherapy by Type in 2015
Table Application of Cancer Immunotherapy
Figure United States Sales Market Share of Cancer Immunotherapy by Application in 2015
Figure United States Cancer Immunotherapy Sales and Growth Rate (2011-2021)
Figure United States Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Table United States Cancer Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Sales Share by Manufacturers
Figure 2016 Cancer Immunotherapy Sales Share by Manufacturers
Table United States Cancer Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 United States Cancer Immunotherapy Revenue Share by Manufacturers
Table United States Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015
Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers
Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers
Table United States Cancer Immunotherapy Sales by Type (2012-2017)
Table United States Cancer Immunotherapy Sales Share by Type (2012-2017)
Figure United States Cancer Immunotherapy Sales Market Share by Type in 2015
Table United States Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
Table United States Cancer Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Immunotherapy by Type (2012-2017)
Table United States Cancer Immunotherapy Price by Type (2012-2017)
Figure United States Cancer Immunotherapy Sales Growth Rate by Type (2012-2017)
Table United States Cancer Immunotherapy Sales by Application (2012-2017)
Table United States Cancer Immunotherapy Sales Market Share by Application (2012-2017)
Figure United States Cancer Immunotherapy Sales Market Share by Application in 2015
Table United States Cancer Immunotherapy Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Immunotherapy Sales Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Immunotherapy Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Immunotherapy Market Share (2012-2017)
Table F. Hoffman La-Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffman La-Roche Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffman La-Roche Cancer Immunotherapy Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Cancer Immunotherapy Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Immunotherapy Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly and Company Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Cancer Immunotherapy Market Share (2012-2017)
Table Janssen Global Services Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Global Services Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Global Services Cancer Immunotherapy Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Immunotherapy Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Immunotherapy Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure United States Cancer Immunotherapy Production and Growth Rate Forecast (2017-2021)
Figure United States Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Table United States Cancer Immunotherapy Production Forecast by Type (2017-2021)
Table United States Cancer Immunotherapy Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
Pfizer
Seattle Genetics
Peregrine Pharmaceuticals
Viralytics Ltd
Immunomedics
